A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
Neutralizing antibody titers in SARS-CoV-2 infected or vaccinated people are an important measure for vaccine development and public health decision-making. Here, the authors develop a fluorescence based SARS-CoV-2 assay to determine neutralizing antibody titers in COVID-19 patient sera in a high th...
Guardado en:
Autores principales: | Antonio E. Muruato, Camila R. Fontes-Garfias, Ping Ren, Mariano A. Garcia-Blanco, Vineet D. Menachery, Xuping Xie, Pei-Yong Shi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/499223ae65ff4240a356584c5f5e87e6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
por: Antonio E. Muruato, et al.
Publicado: (2021) -
Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19
por: Xuping Xie, et al.
Publicado: (2021) -
The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization
por: Jing Zou, et al.
Publicado: (2021) -
Antibody Landscape Analysis following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection Assay
por: Zhu-Nan Li, et al.
Publicado: (2021) -
A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies
por: Adrian Creanga, et al.
Publicado: (2021)